Human cytomegalovirus pp65 lower matrix protein: A humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice

Clinical and Experimental Immunology

Volumn 143, Issue 1, 2006, Pages 167-179

  Chang, M ^a   Pan, M R ^b   Chen, D Y ^c   Lan, J L ^c  

^a TZU CHI UNIVERSITY   (Taiwan)

^b Equity Investment Department   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Autoantibody; Autoimmunity; Cytomegalovirus; pp65 lower matrix protein; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MATRIX PROTEIN; PROTEIN PP150; PROTEIN PP65; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS PHOSPHOPROTEIN; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; DNA; PHOSPHOPROTEIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BLOOD SAMPLING; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC CODE; GLOMERULONEPHRITIS; HEALTH STATUS; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; OPEN READING FRAME; PLASMID; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SERUM; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; VIRUS PATHOGENESIS; ADOLESCENT; ANIMAL; ANTIBODY PRODUCTION; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; KIDNEY; METHODOLOGY; MIDDLE AGED; NEW ZEALAND BLACK MOUSE; PATHOLOGY; VACCINATION;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODY FORMATION; AUTOANTIBODIES; CELLS, CULTURED; CYTOMEGALOVIRUS; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOBLOTTING; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NZB; MIDDLE AGED; PHOSPHOPROTEINS; VACCINATION; VIRAL MATRIX PROTEINS;

EID: 33644825842     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02974.x     Document Type: Article

References (47)

1. Nichols WG Boeckh M Recent advances in the therapy and prevention of CMV infections J Clin Virol 2000 16 25 40
2. Sekigawa I Nawata M Seta N Yamada M Iida N Hashimoto H Cytomegalovirus infection in patients with systemic lupus erythematosus Clin Exp Rheumatol 2002 20 559 64
3. Newkirk MM van Venrooij WJ Marshall GS Autoimmune response to U1 small nuclear ribonucleoprotein (U1 snRNP) associated with cytomegalovirus infection Arthritis Res 2001 3 253 8
4. Rider JR Ollier WE Lock RJ Brookes ST Pamphilon DH Human cytomegalovirus infection and systemic lupus erythematosus Clin Exp Rheumatol 1997 15 405 9
5. Fairweather D Lawson CM Chapman AJ et al. Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross-react with virus and cardiac myosin Immunology 1998 94 263 70
6. Stratta P Canavese C Ciccone G et al. Correlation between cytomegalovirus infection and Raynaud's phenomenon in lupus nephritis Nephron 1999 82 145 54
7. Baboonian C Venables PJ Booth J Williams DG Roffe LM Maini RN Virus infection induces redistribution and membrane localization of the nuclear antigen La (SS-B): a possible mechanism for autoimmunity Clin Exp Immunol 1989 78 454 9
8. Andersen P Molgaard J Andersen I Andersen HK Smooth-muscle antibodies and antibodies to cytomegalovirus and Epstein-Barr virus in leukaemias and lymphomata Acta Pathol Microbiol Scand 1976 84 86 92
9. Hayes K Alford C Britt W Antibody response to virus-encoded proteins after cytomegalovirus mononucleosis J Infect Dis 1987 156 615 21
10. Fujinami RS Nelson JA Walker L Oldstone MB Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression J Virol 1988 62 100 5
11. Magro CM Allen J Pope-Harman A et al. The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis Am J Clin Pathol 2003 119 556 67
12. Zhu J Cytomegalovirus infection induces expression of 60 KD/Ro antigen on human keratinocytes Lupus 1995 4 396 406
13. Gharavi AE Pierangeli SS Espinola RG Liu X Colden-Stanfield M Harris EN Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo Arthritis Rheum 2002 46 545 52
14. Curtis HA Singh T Newkirk MM Recombinant cytomegalovirus glycoprotein gB (UL55) induces an autoantibody response to the U1-70 kDa small nuclear ribonucleoprotein Eur J Immunol 1999 29 3643 53
15. Chapman AJ Farrell HE Thomas JA et al. A murine cytomegalovirus- neutralizing monoclonal antibody exhibits autoreactivity and induces tissue damage in vivo Immunology 1994 81 435 43
16. Zaia JA Forman SJ Ting YP Vanderwal-Urbina E Blume KG Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients J Infect Dis 1986 153 780 7
17. Jahn G Scholl BC Traupe B Fleckenstein B The two major structural phosphoproteins (pp65 and pp150) of human cytomegalovirus and their antigenic properties J Gen Virol 1987 68 1327 37
18. Gallez-Hawkins G Lomeli NA X LL et al. Kinase-deficient CMVpp65 triggers a CMVpp65 specific T-cell immune response in HLA-A*0201.Kb transgenic mice after DNA immunization Scand J Immunol 2002 55 592 8
19. + T-cell responses to CMV in HIV-1-infected subjects Virology 2001 279 459 70
20. Morello CS Cranmer LD Spector DH Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65) J Virol 2000 74 3696 708
21. Gyulai Z Endresz V Burian K et al. Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB. 150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs J Infect Dis 2000 181 1537 46
22. Morello CS Cranmer LD Spector DH In vivo replication, latency, and immunogenicity of murine cytomegalovirus mutants with deletions in the M83 and M84 genes, the putative homologs of human cytomegalovirus pp65 (UL83) J Virol 1999 73 7678 93
23. Lu SC Chin LT Wu FM et al. Seroprevalence of CMV antibodies in a blood donor population and premature neonates in south-central Taiwan Kaohsiung J Med Sci 1999 15 603 10
24. Tsai WS Chang MH Chen JY Lee CY Liu YG Seroepidemiological study of Epstein-Barr virus infection in children in Taipei Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1989 30 81 6
25. McClain MT Harley JB James JA The role of Epstein-Barr virus in systemic lupus erythematosus Front Biosci 2001 6 E137 47
26. James JA Harley JB Scofield RH Role of viruses in systemic lupus erythematosus and Sjogren syndrome Curr Opin Rheumatol 2001 13 370 6
27. Kaufman KM Kirby MY Harley JB James JA Peptide mimics of a major lupus epitope of SmB/B′ Ann NY Acad Sci 2003 987 215 29
28. Arbuckle MR McClain MT Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus N Engl J Med 2003 349 1526 33
29. Bombardier C Gladman DD Urowitz MB Caron D Chang CH Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992 35 630 40
30. Prevoo ML van ''t Hof MA Kuper HH van Leeuwen MA van de Putte LB van Riel PL Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 1995 38 44 8
31. Valentini G Della Rossa A Bombardieri S et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes Ann Rheum Dis 2001 60 592 8
32. Valentini G Bencivelli W Bombardieri S et al. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria Ann Rheum Dis 2003 62 901 3
33. Valentini G Silman AJ Veale D Assessment of disease activity Clin Exp Rheumatol 2003 21 S39 41
34. Wolfram B Hartmut H Ulrich HK A mouse model for cytomegalovirus. In: Coligan EJ Kruisbeek AM Margulies DH Shevach EM Strober W, eds Current protocols in immunology New York John Wiley & Sons, Inc. 2001 :19.7.1 7 3
35. Chang M Walker SE Hoffman RW Immunization with a bacterial ATP-binding cassette transporter fragment suppresses autoimmunity and prolongs survival in MRL/lpr lupus-prone mice Lupus 2000 9 655 63
36. Szewczyk B Pilat Z Bienkowska-Szewczyk K Summers DF Elution of glycoproteins from replicas of sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels Electrophoresis 1998 19 220 3
37. Chang M Wang RJ Yangco DT Sharp GC Komatireddy GR Hoffman RW Analysis of autoantibodies against RNA polymerases using immunoaffinity-purifed RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay Clin Immunol Immunopathol 1998 89 71 8
38. Fredriksen K Brannsether B Traavik T Rekvig OP Antibodies to viral and mammalian native DNA in response to BK virus inoculation and subsequent immunization with calf thymus DNA Scand J Immunol 1991 34 109 19
39. McMurray R Keisler D Kanuckel K Izui S Walker SE Prolactin influences autoimmune disease activity in the female B/W mouse J Immunol 1991 147 3780 7
40. James JA Neas BR Moser KL et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure Arthritis Rheum 2001 44 1122 6
41. + virus-specific cytotoxic T lymphocytes J Med Virol 1994 43 103 10
42. Boppana SB Britt WJ Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells Virology 1996 222 293 6
43. Pande H Campo K Tanamachi B Forman SJ Zaia JA Direct DNA immunization of mice with plasmid DNA encoding the tegument protein pp65 (ppUL83) of human cytomegalovirus induces high levels of circulating antibody to the encoded protein Scand J Infect Dis Suppl 1995 99 117 20
44. Morello CS Ye M Spector DH Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication J Virol 2002 76 4822 35
45. Putterman C Diamond B Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition J Exp Med 1998 188 29 38
46. Marshall BC McPherson RA Greidinger E Hoffman R Adler SP Lack of autoantibody production associated with cytomegalovirus infection Arthritis Res 2002 4 R6
47. Mok CC Lau CS Pathogenesis of systemic lupus erythematosus J Clin Pathol 2003 56 481 90